nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A1—Lisinopril—dilated cardiomyopathy	0.847	1	CbGbCtD
Ceftibuten—Drug fever—Spironolactone—dilated cardiomyopathy	0.0173	0.121	CcSEcCtD
Ceftibuten—Cholestasis—Furosemide—dilated cardiomyopathy	0.00413	0.0288	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00377	0.0263	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0032	0.0223	CcSEcCtD
Ceftibuten—Renal failure—Spironolactone—dilated cardiomyopathy	0.00317	0.0221	CcSEcCtD
Ceftibuten—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00301	0.021	CcSEcCtD
Ceftibuten—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00294	0.0205	CcSEcCtD
Ceftibuten—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00274	0.0191	CcSEcCtD
Ceftibuten—Cefepime—SLC22A5—dilated cardiomyopathy	0.00269	0.268	CrCbGaD
Ceftibuten—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00252	0.0176	CcSEcCtD
Ceftibuten—Irritability—Furosemide—dilated cardiomyopathy	0.00217	0.0152	CcSEcCtD
Ceftibuten—Dehydration—Furosemide—dilated cardiomyopathy	0.00212	0.0148	CcSEcCtD
Ceftibuten—Cefixime—SLC22A5—dilated cardiomyopathy	0.0021	0.21	CrCbGaD
Ceftibuten—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00206	0.0144	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00205	0.0143	CcSEcCtD
Ceftibuten—Ceftazidime—SLC22A5—dilated cardiomyopathy	0.00198	0.197	CrCbGaD
Ceftibuten—Cefdinir—SLC22A5—dilated cardiomyopathy	0.00194	0.194	CrCbGaD
Ceftibuten—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00189	0.0132	CcSEcCtD
Ceftibuten—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00188	0.0131	CcSEcCtD
Ceftibuten—Somnolence—Spironolactone—dilated cardiomyopathy	0.00183	0.0128	CcSEcCtD
Ceftibuten—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00179	0.0125	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00178	0.0124	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00174	0.0121	CcSEcCtD
Ceftibuten—Renal failure—Furosemide—dilated cardiomyopathy	0.00172	0.012	CcSEcCtD
Ceftibuten—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00164	0.0114	CcSEcCtD
Ceftibuten—Urticaria—Spironolactone—dilated cardiomyopathy	0.00163	0.0114	CcSEcCtD
Ceftibuten—Irritability—Lisinopril—dilated cardiomyopathy	0.00163	0.0114	CcSEcCtD
Ceftibuten—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00163	0.0113	CcSEcCtD
Ceftibuten—Dehydration—Lisinopril—dilated cardiomyopathy	0.00159	0.0111	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00154	0.0107	CcSEcCtD
Ceftibuten—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00152	0.0106	CcSEcCtD
Ceftibuten—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00149	0.0104	CcSEcCtD
Ceftibuten—Pruritus—Spironolactone—dilated cardiomyopathy	0.00146	0.0102	CcSEcCtD
Ceftibuten—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00141	0.00982	CcSEcCtD
Ceftibuten—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0014	0.00978	CcSEcCtD
Ceftibuten—Dysuria—Lisinopril—dilated cardiomyopathy	0.00138	0.00963	CcSEcCtD
Ceftibuten—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00138	0.00963	CcSEcCtD
Ceftibuten—Dizziness—Spironolactone—dilated cardiomyopathy	0.00136	0.00949	CcSEcCtD
Ceftibuten—Flatulence—Furosemide—dilated cardiomyopathy	0.00135	0.00943	CcSEcCtD
Ceftibuten—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00134	0.00937	CcSEcCtD
Ceftibuten—Cefalotin—SLC22A5—dilated cardiomyopathy	0.00131	0.131	CrCbGaD
Ceftibuten—Vomiting—Spironolactone—dilated cardiomyopathy	0.00131	0.00913	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00131	0.00911	CcSEcCtD
Ceftibuten—Rash—Spironolactone—dilated cardiomyopathy	0.0013	0.00905	CcSEcCtD
Ceftibuten—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0013	0.00904	CcSEcCtD
Ceftibuten—Renal failure—Lisinopril—dilated cardiomyopathy	0.00129	0.00903	CcSEcCtD
Ceftibuten—Headache—Spironolactone—dilated cardiomyopathy	0.00129	0.00899	CcSEcCtD
Ceftibuten—Jaundice—Lisinopril—dilated cardiomyopathy	0.00128	0.00895	CcSEcCtD
Ceftibuten—Agitation—Furosemide—dilated cardiomyopathy	0.00126	0.00879	CcSEcCtD
Ceftibuten—Haematuria—Lisinopril—dilated cardiomyopathy	0.00126	0.00876	CcSEcCtD
Ceftibuten—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00123	0.00857	CcSEcCtD
Ceftibuten—Nausea—Spironolactone—dilated cardiomyopathy	0.00122	0.00853	CcSEcCtD
Ceftibuten—Dry mouth—Furosemide—dilated cardiomyopathy	0.00114	0.00797	CcSEcCtD
Ceftibuten—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00112	0.00781	CcSEcCtD
Ceftibuten—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00112	0.0078	CcSEcCtD
Ceftibuten—Anorexia—Furosemide—dilated cardiomyopathy	0.00107	0.00744	CcSEcCtD
Ceftibuten—Chills—Lisinopril—dilated cardiomyopathy	0.00106	0.0074	CcSEcCtD
Ceftibuten—Flatulence—Lisinopril—dilated cardiomyopathy	0.00101	0.00707	CcSEcCtD
Ceftibuten—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00101	0.00703	CcSEcCtD
Ceftibuten—Paraesthesia—Furosemide—dilated cardiomyopathy	0.001	0.00701	CcSEcCtD
Ceftibuten—Somnolence—Furosemide—dilated cardiomyopathy	0.000995	0.00694	CcSEcCtD
Ceftibuten—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000973	0.00679	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000966	0.00674	CcSEcCtD
Ceftibuten—Fatigue—Furosemide—dilated cardiomyopathy	0.000965	0.00673	CcSEcCtD
Ceftibuten—Constipation—Furosemide—dilated cardiomyopathy	0.000957	0.00668	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000915	0.00639	CcSEcCtD
Ceftibuten—Urticaria—Furosemide—dilated cardiomyopathy	0.000889	0.0062	CcSEcCtD
Ceftibuten—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000885	0.00617	CcSEcCtD
Ceftibuten—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000885	0.00617	CcSEcCtD
Ceftibuten—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000856	0.00598	CcSEcCtD
Ceftibuten—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00084	0.00586	CcSEcCtD
Ceftibuten—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000824	0.00575	CcSEcCtD
Ceftibuten—Asthenia—Furosemide—dilated cardiomyopathy	0.000803	0.0056	CcSEcCtD
Ceftibuten—Anorexia—Lisinopril—dilated cardiomyopathy	0.0008	0.00558	CcSEcCtD
Ceftibuten—Pruritus—Furosemide—dilated cardiomyopathy	0.000792	0.00552	CcSEcCtD
Ceftibuten—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000766	0.00534	CcSEcCtD
Ceftibuten—Insomnia—Lisinopril—dilated cardiomyopathy	0.000759	0.0053	CcSEcCtD
Ceftibuten—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000754	0.00526	CcSEcCtD
Ceftibuten—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000748	0.00522	CcSEcCtD
Ceftibuten—Somnolence—Lisinopril—dilated cardiomyopathy	0.000746	0.00521	CcSEcCtD
Ceftibuten—Dizziness—Furosemide—dilated cardiomyopathy	0.00074	0.00516	CcSEcCtD
Ceftibuten—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000739	0.00516	CcSEcCtD
Ceftibuten—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00073	0.00509	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000725	0.00506	CcSEcCtD
Ceftibuten—Fatigue—Lisinopril—dilated cardiomyopathy	0.000724	0.00505	CcSEcCtD
Ceftibuten—Constipation—Lisinopril—dilated cardiomyopathy	0.000718	0.00501	CcSEcCtD
Ceftibuten—Vomiting—Furosemide—dilated cardiomyopathy	0.000711	0.00496	CcSEcCtD
Ceftibuten—Rash—Furosemide—dilated cardiomyopathy	0.000705	0.00492	CcSEcCtD
Ceftibuten—Dermatitis—Furosemide—dilated cardiomyopathy	0.000705	0.00492	CcSEcCtD
Ceftibuten—Headache—Furosemide—dilated cardiomyopathy	0.000701	0.00489	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000686	0.00479	CcSEcCtD
Ceftibuten—Urticaria—Lisinopril—dilated cardiomyopathy	0.000667	0.00465	CcSEcCtD
Ceftibuten—Nausea—Furosemide—dilated cardiomyopathy	0.000665	0.00464	CcSEcCtD
Ceftibuten—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000664	0.00463	CcSEcCtD
Ceftibuten—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000664	0.00463	CcSEcCtD
Ceftibuten—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000619	0.00432	CcSEcCtD
Ceftibuten—Asthenia—Lisinopril—dilated cardiomyopathy	0.000602	0.0042	CcSEcCtD
Ceftibuten—Pruritus—Lisinopril—dilated cardiomyopathy	0.000594	0.00415	CcSEcCtD
Ceftibuten—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000574	0.00401	CcSEcCtD
Ceftibuten—Dizziness—Lisinopril—dilated cardiomyopathy	0.000555	0.00387	CcSEcCtD
Ceftibuten—Vomiting—Lisinopril—dilated cardiomyopathy	0.000534	0.00373	CcSEcCtD
Ceftibuten—Rash—Lisinopril—dilated cardiomyopathy	0.000529	0.00369	CcSEcCtD
Ceftibuten—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000529	0.00369	CcSEcCtD
Ceftibuten—Headache—Lisinopril—dilated cardiomyopathy	0.000526	0.00367	CcSEcCtD
Ceftibuten—Nausea—Lisinopril—dilated cardiomyopathy	0.000499	0.00348	CcSEcCtD
